Immunotherapy

A vast amount of studies suggest that immunotherapy may represent an effective new treatment approach for malignant mesothelioma. Learn your options here.

Asbestos | Biomarkers | Diagnosis | Immune Systems | Immunotherapy | Research | Treatments | Updates

Immunotherapy for Mesothelioma: Who Are the Best Candidates?
ByAlex Strauss November 6, 2017November 6, 2017

Immunotherapy is emerging as one of the most promising new treatment approaches for a wide range of cancers, including malignant…

Read More Immunotherapy for Mesothelioma: Who Are the Best Candidates?
Asia | Biomarkers | Diagnosis | Immune Systems | Immunotherapy | International | Prognosis | Research | Treatments

Inflammation Marker May Predict Mesothelioma Prognosis
ByAlex Strauss September 20, 2017March 19, 2019

The ratio of neutrophils to lymphocytes – a way of measuring inflammation in the body of people with malignant pleural…

Read More Inflammation Marker May Predict Mesothelioma Prognosis
Europe | Immune Systems | Immunotherapy | International | New Drugs | Prognosis | Research | Treatments

Using Immune Cells to Predict Mesothelioma Outcomes
ByAlex Strauss August 22, 2017August 23, 2017

Immune system cells may be some of the best predictors of mesothelioma outcomes, according to a group of British scientists.…

Read More Using Immune Cells to Predict Mesothelioma Outcomes
Asia | Biomarkers | Diagnosis | Immune Systems | Immunotherapy | International | Prognosis | Research | Treatments

These Proteins Appear to Shorten Mesothelioma Survival
ByAlex Strauss August 17, 2017

New evidence suggests that mesothelioma patients whose tumors express two particular proteins do not live as long as other mesothelioma…

Read More These Proteins Appear to Shorten Mesothelioma Survival
Immune Systems | Immunotherapy | International | New Drugs | New Studies | Research | Treatments

Second-Line Immunotherapy Treatment Fails to Improve Mesothelioma Survival
ByAlex Strauss July 23, 2017

A large international clinical trial of the immunotherapy drug tremelimumab as a second- or third-line treatment option for malignant mesothelioma…

Read More Second-Line Immunotherapy Treatment Fails to Improve Mesothelioma Survival
Asbestos | Australia | Immune Systems | Immunotherapy | International | Mesothelioma | Prognosis | Research | Treatments

MicroRNAs May Be Key to Better Immunotherapy for Mesothelioma
ByAlex Strauss June 23, 2017

Australian scientists say it may be possible to artificially reduce the levels of a protein that helps mesothelioma tumors hide…

Read More MicroRNAs May Be Key to Better Immunotherapy for Mesothelioma
Alternatives | Immune Systems | Immunotherapy | Multi-Modality Therapy | Prognosis | Research | Treatments | Virus

Altered Viruses May Help Boost Immunotherapy for Malignant Mesothelioma
ByAlex Strauss May 31, 2017

Viruses may soon be playing a bigger role in the fight against malignant mesothelioma and other thoracic cancers. A pair…

Read More Altered Viruses May Help Boost Immunotherapy for Malignant Mesothelioma
Immune Systems | Immunotherapy | Multi-Modality Therapy | New Studies | Radiation Therapy | Research

Immunotherapy and Radiation: A Powerful Mesothelioma Combo
ByAlex Strauss May 23, 2017March 1, 2018

New research suggests that, in the battle against malignant pleural mesothelioma, a treatment combining immunotherapy drugs with radiotherapy may be a powerful…

Read More Immunotherapy and Radiation: A Powerful Mesothelioma Combo
Immune Systems | Immunotherapy | New Drugs | New Studies | Research | Treatments

MS Drug May Help Treat Malignant Mesothelioma, Too
ByAlex Strauss April 8, 2017May 10, 2017

Preliminary tests of a potential new mesothelioma treatment have yielded some exciting results at the University of Hawaii Cancer Center.…

Read More MS Drug May Help Treat Malignant Mesothelioma, Too
Alternatives | Biological Therapy | Immune Systems | Immunotherapy | Research | Treatments

The Key to Mesothelioma Treatment Success with Immunotherapy
ByAlex Strauss April 2, 2017May 10, 2017

Researchers with a biotechnology company that makes antibody-drug conjugates (ADC) for hard-to-treat cancers like malignant mesothelioma say careful patient selection…

Read More The Key to Mesothelioma Treatment Success with Immunotherapy

1 (888) 378-1331

Immunotherapy

Immunotherapy for Mesothelioma: Who Are the Best Candidates?

Inflammation Marker May Predict Mesothelioma Prognosis

Using Immune Cells to Predict Mesothelioma Outcomes

These Proteins Appear to Shorten Mesothelioma Survival

Second-Line Immunotherapy Treatment Fails to Improve Mesothelioma Survival

MicroRNAs May Be Key to Better Immunotherapy for Mesothelioma

Altered Viruses May Help Boost Immunotherapy for Malignant Mesothelioma

Immunotherapy and Radiation: A Powerful Mesothelioma Combo

MS Drug May Help Treat Malignant Mesothelioma, Too

The Key to Mesothelioma Treatment Success with Immunotherapy

United States Sources

Centers for Disease Control and Prevention (CDC), UNITED STATES

Creighton University School of Medicine, UNITED STATES

David Geffen School of Medicine, UCLA, UNITED STATES

Icahn School of Medicine at Mount Sinai, New York, UNITED STATES

Mayo Clinic, UNITED STATES

Moffitt Cancer Center, Tampa, FL, UNITED STATES

National Institute for Occupational Safety & Health, UNITED STATES

University of Chicago, Medical Center, UNITED STATES

University of Maryland School of Medicine, UNITED STATES

University of Hawaii Cancer Center, UNITED STATES

Wake Forest University School of Medicine, UNITED STATES